TPG and General Atlantic are among the PE firms circling Clinical Ink, a clinical trial tech business owned by GI Partners, Axios Pro has learned. Private equity and strategic acquirers have been active consolidators of clinical trial technology.
Read the full article: TPG and General Atlantic Circle Clinical Ink //
Source: https://www.axios.com/pro/health-tech-deals/2026/06/08/tpg-general-atlantic-clinical-ink